INTRODUCTION
Ligandin (Y protein)' is a basic protein isolated from supernates of human and rat liver homogenates that binds various organic anions in vivo and in vitro, and is considered to be an important determinant in their transfer from plasma into parenchymal liver cells (1) (2) (3) (4) (5) (6) . Immunodiffusion analysis with a monospecific antiserum against rat liver ligandin demonstrated an immunologically similar protein in kidney (6) , which, on immunofluorescent analysis, is restricted to the proximal tubular cells (7) .
We have now studied physicochemical and immunological characteristics of this renal tubular protein in rat kidney, its ability to bind organic anions, and its possible role in proximal tubular transport of organic anions.
METHODS
Adult male Sprague-Dawley rats weighing 250-350 g were anesthetized with ether. The kidneys were removed, immediately washed in ice-cold isotonic saline, weighed, and perfused through hilar vessels with 2.5 ml isotonic saline at 4°C to remove as much blood as possible. A (8) , and BSP-GSH was prepared synthetically (9) . The purity of each organic anion studied was established by thin-layer chromatography in at least two solvent systems with subsequent serial elution and either colorimetric or radio-isotopic localization. Purity of conjugated bilirubin was 78%, whereas all other organic anions studied were 98-100%o pure. Organic anions were determined spectrophotometrically: BSP 580 nm after alkalinization, heme 410 nm, bilirubin 460 nm, and PSP 560 nm. When labeled organic anions were used, samples were counted in an Intertechnique liquid scintillation spectrophotometer (model SL40, Intertechnique, Dover, N. J.). Aquasol (New England Nuclear) was the scintillation fluid and all samples were corrected for quenching with an external standard. Efficiency of counting was 60-85% for 14C and 20-35% for 3H. Radioactivity was expressed in disintegrations per minute. Organic anion binding to various proteins was quantitated by integration of the area under each peak. When performed in a standardized manner (1), this procedure provides reproducible relative binding of organic anions to the various supernatant protein fractions. To exclude minor variations in amounts of protein or organic anions applied to the column (1), results were expressed as a fraction of the total protein-bound organic anion eluted from the column up to 2.5 times the void volume.
To identify specific proteins in the various organic anionbinding fractions obtained by G-100 chromatography, immunodiffusion analysis against monospecific antisera prepared against purified rat albumin and liver ligandin was performed with each fraction (6) .
To determine whether organic anion binding in the Y fraction (1) obtained by gel filtration of the kidney supernate was due to a protein that reacts immunologically with anti-liver ligandin, the following experiment was performed. 5-ml samples of Y fraction obtained by Sephadex G-100 chromatography of the supernate of 25% kidney homogenate were added to tubes containing 5 ml of isotonic saline, monospecific anti-rat liver ligandin IgG or nonspecific rabbit IgG as previously described (6) . The mixtures were separately stirred at room temperature for 1 h and at 4VC for 48 h after which they were centrifuged at 18,000 g for 30 min and any precipitates were separated from the supernatant fractions. 5 mg BSP was added to each of the three supernatant Y fractions; the mixtures were rechromatographed on a G-100 Sephadex column, and BSP binding was determined as described.
Competitive binding of various organic anions to renal proteins was studied in vivo. Male Sprague Dawley rats, weighing 250-300 g, given rat breeder chow and water ad libitum, were anesthetized with intraperitoneal barbiturate. Temperature was continually monitored by rectal thermometer and, where necessary, artificially maintained at 37-38°C by an incandescent lamp. The following organic anions were injected intravenously: [3H]PAH (107 dpm), [14C]benzyl penicillin (107 dpm), BSP (25 mg), and probenecid (50 mg). Injection volume was adjusted to 1 ml by addition of isotonic saline. All injections were performed manually over a period of 1 min with a tuberculin syringe. Precisely 5 min after completion of injection, blood was obtained by cardiac puncture and the kidneys were promptly removed, placed in iced normal saline, and perfused. 5 min was chosen to allow one circulation of the entire blood volume through the kidneys (10) . Kidney homogenates always contained small amounts of blood and presumably tubular urine, which were not completely removed by perfusion, although radioactivity in the perfusate was less than 100 dpm/0.2 ml aliquot. After kidney homogenization, supernates were prepared and chromatographed as described. Additional studies were performed with heme-containing supernates of 25% homogenates of unperfused kidneys from Sprague-Dawley rats and bilirubin-containing supernates of kidneys from homozygous Gunn rats.
To study competition between penicillin, probenecid, and BSP for binding to renal proteins, the urethra was clamped.
['4C]penicillin (10 dpm) was diluted with 10 mg of nonradioactive benzyl penicillin (potassium salt) and simultaneously injected with isotonic saline, nonradioactive probenecid (50 mg) and BSP (25 mg). Immediately after ligation of the renal pedicles and removal of the kidneys, the urinary bladder was emptied with a microsyringe (Hamilton Co., Reno, Nev.) after injection into the bladder of 0.2-0.5 ml of isotonic saline. Total volume of fluid aspirated was recorded, 10-20 Id of bladder content was used for counting of radioactivity, and total bladder content of radioactive penicillin was calculated. The kidneys and liver were weighed and a 50%, homogenate was prepared in isotonic saline at 4°C. The total volume of homogenate was measured and 0.1-0.2 ml samples were used for counting of radioactivity. Total plasma radioactivity was calculated from the product of plasma radioactivity and plasma volume. The latter was derived from weight in kilograms X 40. 4 
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R. Kirsch, G. Fleischner, K. Kamisaka, and I. M. Arias ml (11) . Renal radioactivity was determined by counting 0.1 ml of homogenate and calculating total renal radioactivity. Radioactivity of supernatant fluid and elution fractions from G-100 Sephadex chromatography was similarly determined. Radioactivity in total plasma, urinary bladder, and kidney and liver homogenates was expressed as a percentage of the dose injected and as the radioactivity ratio in total kidney/total plasma. The relative amount of penicillin radioactivity bound to various proteins was also expressed as a percentage of total protein-bound penicillin radioactivity.
The Bi-mercaptoethanol (14) . Molecular weight was estimated by comparative analysis after simultaneous electrophoresis of appropriate standards. After hydrolysis of 100 ,ug of purified protein in 6 N HCl for 16 h at 110°C, amino acid analysis was determined on the hydrolysate with a Beckman model 120 C amino acid analyzer (Beckman Instruments, Inc., Fullerton, Calif.). Comparative isoelectric focusing, gel electrophoresis, and amino acid analysis were performed with liver ligandin purified identically (7).
6-mo-old male New Zealand rabbits were used for antisera production. Preimmunization sera showed no precipitation reactions on immunodiffusion against renal supernate, purified renal protein, or hepatic ligandin. Renal protein (50 /g) was dissolved in 1.0 ml phosphate-buffered saline, pH 7.4, and added to 1.5 ml complete Freund's adjuvant (Difco Laboratories, Detroit, Mich.) containing 10 mg of mycobacterium. The mixture was homogenized for 2.5 min at top speed in a Sorvall (Sorvall-Dupont Instruments, Sorvall Operations, Newtown, Conn.) omni-homogenizer (micro attachment) (6) . The emulsion was injected in 0.1 ml amounts at multiple sites into the foot pads and back of the rabbits. Additional multiple intracutaneous injections of 100,gg renal protein and incomplete Freund's adjuvant were performed 3 wk later. When an antibody was produced, as evidenced by a precipitation reaction with a 1: 8 dilution of rabbit serum and renal protein (100 /ug/ml), the animals were bled, blood was allowed to clot at room temperature for 1 h and then placed at 4VC for 24 h, after which serum was removed and centrifuged in a Sorvall centrifuge at 4,000 g for 30 min at 4VC.
The specificity of the antibody was tested by immunodiffusion (12) and immunoelectrophoresis (15) against 1: 8 dilutions of rat liver, kidney, and small intestinal mucosal supernates of 25% homogenates as well as serum, hepatic ligandin, and renal organic binding protein.
Immunologic identity between renal organic anion-binding protein and hepatic ligandin was also studied. Anti-liver ligandin IgG and anti-kidney organic anion-binding protein serum were tested against supernates of rat liver and kidney before and after absorption by each antibody preparation. 100
,gl of liver and renal supernates were added separately to tubes containing either 800 ,ul of antiserum against renal organic anion-binding protein, anti-liver ligandin IgG, or saline. After 48 h incubation at 4°C, the tubes were centrifuged at 18,000 g for 30 min. Supernatant fluid was removed and tested by immunodiffusion against renal organic anion-binding protein anti-serum or anti-hepatic ligandin IgG.
Immunoquantitation of liver ligandin and renal organic anion-binding protein was performed by radial immunodiffusion (16) . With a microsyringe (Hamilton Co.), 8 Al of 1: 8 dilutions of kidney or liver supernates of 25% homogenates was placed in each well. Each assay was performed in duplicate and each plate contained three standard dilutions of purified protein ranging from 75 to 400 ,ug/ml. Plates were kept at room temperature in a moisture chamber for 48 h and photographed at a constant magnification, and precipitation rings were carefully cut and weighed. Results were expressed as micrograms ligandin per milligram tissue supernatant protein (6) . Protein was quantitated with twicecrystalized bovine serum albumin as a standard (17) .
Circular dichroism was utilized to study secondary structure of purified renal organic anion-binding protein and ligandin-protein interaction with a Cary Model 60 recording spectropolarimeter (Cary Instruments, Monrovia, Calif.) (18) (19) (20) . Renal organic anion-binding protein and hepatic ligandin were studied separately and in combination with various organic anions to compare structure, binding sites, and binding affinities. Absorbance was kept below 2 by cell path lengths of 10 mm. Slit width was programed for a band width of 15 A, the time constant was 3 and the scale setting was 0.01. The spectral range studied was between 600 and 270 nm. The a helical component of ligandin was determined by a computer with standards as described by volume; the second occurred at 1.4 times the void volume, and the third, the major organic anion-binding peak, occurred at 1.8 times the void volume. By immunodiffusion, albumin was restricted to the second binding peak, and anti-rat albumin selectively precipitated 95% of radioactivity bound in this fraction. Reactivity to anti-hepatic ligandin was restricted to the third binding peak.
Repeated Sephadex chromatography of supernates to which penicillin was added in vitro revealed a constant pattern of binding. Validity of the gel filtration technique for comparative assessment of organic anion binding to supernatant protein has been established (1, 4) . The reproducibility of the technique is further indicated by results obtained from six separate experiments with renal supernate and [14C]benzyl penicillin. In these experiments, the void volume peak accounted for 14.2±1.7% (mean±SEM) of total protein-bound radioactivity. The albumin-containing peak accounted for 31.5±1.8% and the peak containing protein that reacts with anti-liver ligandin IgG accounted for 53.0± 1.4% of total bound radioactivity. The following other organic anions were bound to the same three peaks and similar reproduceability was demonstrated: BSP, BSP-GSH, bilirubin, conjugated bilirubin, PAH, PSP, phlorizin, heme, and probenecid. From 10 to 48% of each organic anion added in vitro was bound to renal supernatant protein, and 53-90% of each organic anion bound to renal supernate was bound to the third protein peak (Table I) . When kidneys containing blood were homogenized and similarly chromatographed, heme (410 nm) was almost entirely restricted to the third organic anion-binding peak. When supernatant from 25% homogenates of homozygous Gunn rat kid- neys was chromatographed, the bilirubin-binding pattern was the same as observed after addition of bilirubin to homogenates of kidney from normal rats. The contribution of the protein that reacts with antirat ligandin to the major organic anion-binding peak obtained by gel filtration was assessed by incubating the G-100 Y fraction with anti-rat liver ligandin IgG, nonspecific IgG, and isotonic saline (Fig. 2) . In tubes to which isotonic saline was added, a dye-binding peak was found at 1.8 times the void volume. Addition of nonspecific IgG did not alter this binding peak. Addition of monospecific anti-hepatic ligandin IgG virtually obliterated binding by this fraction. The major portion (90%) of the organic anion binding in the peak, occurring at 1.8 times the void volume, was therefore attributed to a renal protein precipitated by antiserum against hepatic ligandin.
Studies were performed to determine whether organic anions bound to the third protein-binding peak in vitro were similarly bound when injected in vivo. The elution patterns obtained from supernates of 25% homogenates prepared from kidneys removed 5 min after i.v. injection of BSP, BSP-GSH, phlorizin, probenecid, conjugated bilirubin, PAH, or penicillin revealed elution patterns similar to those seen when these anions were added in vitro. The ligandin-containing peak contained 52-89%; the second (albumin-containing) peak contained 11-31% and the first peak contained 2-12% of each protein-bound organic anion.
The FIGURE 4 Isoelectric focusing of purified rat kidney ligandin on 6% polyacrylamide gel. Gels containing 6% (wt/ vol) polyacrylamide, 2% (wt/vol) ampholyte, 0.02% (vol/ vol) TEMED, and 0.002% (vol/vol) ammonium persulfate were prepared in 3-mm tubes. Electrolytes were 0.01 M phosphoric acid and 0.02 M sodium hydroxide. Gels were run for 30 min at 1 mA/gel to remove ammonium persulfulate and create a partial pH gradient before 10-50 ,g of renal ligandin in 10-50 Ml was applied. Electrofocusing was performed for 34 h at 1 ml/gel. Gels were stained for 1 h in 0.2% fast green in 40% ethanol, 10% acetic acid, and 50%o water, and destained in 10%o ethanol, 10% acetic acid, and 80%o water. The pH gradient was measured in eluates of gel sections. Gels were sliced with a razor blade into 0.50-cm segments and shaken with 1.0 ml water for 1 h before the pH was measured at a constant temperature. specific antibody prepared against liver ligandin (Fig.  8) . Prior incubation of liver supernate with anti-renal organic anion-binding protein also abolished immunoelectrophoresis reactions between renal supernate and anti-kidney ligandin (Fig. 6) .
Circular dichroism analysis of the renal protein revealed ellipticity minima at 222 and 208 nm, as well as in the peptide absorption region. The molar ellipticity of liver ligandin and the renal protein at 222 nm were similar, indicating that both proteins have very similar overall conformations. Both proteins exhibited approximately 40% helical structure (19) . In the presence of bilirubin, the circular dichroism spectrum revealed three new ellipticity extrema at 405 nm, 455 nm, and 515 nm (Fig. 9) . The 405 nm band increased in magnitude up to a bilirubin protein molar ratio 1:1. The 455 nm band reached 65% saturation after addition of 1 mol of bilirubin and leveled off at a molar ratio between 2 and 3. In contrast, the 515 nm band increased after addition of 2 or more mol of bilirubin. The ellipticity pattern and titration curves at these wavelengths are virtually identical to those obtained with liver ligandin (19) . Addition of increasing amounts of BSP to a solution of the renal protein and bilirubin (molar ratio 1: 1) decreased the magnitude of all three ellipticity bands (Fig. 10) . From these inhibitory effects, the association constant of BSP to renal ligandin was calculated to be 108 M-1. which is also the association constant of BSP binding to hepatic ligandin (19) . PAH, probenecid, and penicillin caused less marked decrease in ellipticity produced by bilirubin and ligandin, with an affinity constant of 10 M1.
The results of binding studies in vivo and in vitro, and physical-chemical, immunological, structural, and binding site investigations indicate that the renal protein is probably identical to hepatic ligandin and will, therefore, be referred to as renal ligandin.
By quantitative radial immunodiffusion, the concentration of hepatic ligandin was 39.5+2.3 ALg/mg supernatant protein (mean±SEM). Treatment with phenobarbital DDT, PCN, or TCDD increased the concentration to 76.4±4.3 (P < 0.001), 80.5+2.7 (P < 0.001), 78.6±3.1, and 83.1+3.2 Ag/mg protein (P < 0.001, respectively). The concentration of renal ligandin in control rats was 31.2±2.2 Ag/mg protein. In TCDD-treated rats, renal ligandin concentration was increased to 49.6 ±2.6 ug/mg protein (P < 0.001) and total kidney weight was not significantly increased (P > 0.5). In contrast to hepatic ligandin, renal ligandin levels were not significantly higher in animals receiving phenobarbital (29.0±3.9, P > 0. 5 Both renal and hepatic ligandin concentrations were unaffected by daily i.p. administration of corn oil for 14 days (P > 0.05) or by single i.p. administration of p-dioxane-corn oil 7 days before study (P > 0.05) (Table III) . Renal ligandin at birth was less than 2 /g/mg protein. Accurate quantitation at this level was not possible.
To study the function of renal ligandin, a competitive study in vivo was performed (Table III, Fig. 11 ). FIGURE 7 Immunodiffusion precipitation between anti-rat kidney ligandin serum (anti KY) and liver ligandin (LY), kidney ligandin (KY), rat serum, and supernate from rat kidney, liver, and small intestinal mucosal homogenates (KS, LS, and GS, respectively). Reduced ratio of renal to plasma penicillin occurred when either BSP or probenecid was simultaneously administered instead of saline (Table III) . Mean plasma penicillin radioactivity at 5 min was higher when BSP or probenecid were administered. The relative amount of radioactivity eluted from G-100 Sephadex columns in the ligandin fraction is shown in Table III . When probenecid or BSP were injected, the relative amount of radioactivity bound to ligandin fraction was significantly reduced, unassociated with any change in percentage of radioactivity in the void volume. The proportion of total protein-bound ligand bound to albumin increased. When renal-to-plasma radioactivity ratios were plotted against the percent of Mean amino acid analysis were performed in duplicate after hydrolysis of 100 mg ligandin purified from rat kidney and liver in 6 N HCl for 16 h at 1100C. Studies relating renal ligandin to organic anion transport were restricted by lack of a mutant strain exhibiting a defect in renal organic anion uptake as well as absence of techniques allowing direct intracellular measurements of ligand and ligandin. These restrictions limit functional studies to correlating organic anion transport with ligandin concentration. Synthesis of ligandin in the kidney, in contrast with hepatic ligandin, was not induced by phenobarbital, DDT, or PCN. However, treatment with TCDD almost doubled the concentration of renal as well as hepatic ligandin.
Immunofluorescence studies in two rats utilizing rhodamine conjugated anti-ligandin IgG suggest that ligandin is localized to the proximal convoluted tubules in TCDD-treated rats, as it is in control rats (unpublished observations). The apparent failure of phenobarbital, DDT, or PCN to alter the concentration of renal ligandin may result from inability of these drugs to enter and bind within the proximal tubular cells, or may reflect different control of renal ligandin when compared with hepatic ligandin. The findings of reduced renal ligandin levels in rats less than 6 h olds, when renal tubular organic anion transport is reduced, resembles results of ontogenetic studies of liver ligandin in rat, monkey, and man (2) .
Additional evidence consistent with the hypothesis that renal ligandin plays a role in organic anion transport by the kidney was obtained by the competitive study in vivo. Probenecid (24) , and hepatic necrosis is observed in rats after administration of doses greatly in excess of those used in the current study. Passive binding of organic anions by ligandin in the renal proximal tubular cell should not increase their net transfer from plasma to urine unless their intracellular concentration directly affects the rate of transport from the cell to the tubular lumen, or unless ligandin is a component of the transport process, presumably in the plasma membrane of the tubular cell. Based primarily on studies using kidney slices, it is believed that the renal organic anion active transport system is located between plasma and tubular cell, and that passive diffusion and reabsorption occur across the tubular cell-lumenal surface (25) . Thus far, with immunofluorescence techniques, ligandin has not been localized to plasma membrane fractions of liver or kidney (unpublished observations). For these reasons, we may only postulate that ligandin is a component in the organic anion translocation system in the proximal tubular cell and regulates the net flux of organic anions into this cell. In TCDD-treated rats, renal plasma [14] Hepatic ligandin purified to homogeneity binds GSH and is identical with GSH transferase B (26), one of five homogenous GSH transferases from rat liver (27) . Renal ligandin also binds GSH and exhibits GSH transferase B activity with chlorodinitrobenzene and ethacrynic acid as substrates (26, 28) . These observations suggest that renal and hepatic ligandin may also function in GSH storage and/or metabolism.
